SB-224289: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
[[Category:Research chemicals]] | [[Category:Research chemicals]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
<gallery> | |||
File:SB-224289.svg|SB-224289 | |||
</gallery> | |||
Latest revision as of 05:32, 3 March 2025
SB-224289 is a chemical compound that acts as a selective antagonist for the 5-HT1B receptor, a subtype of the serotonin receptor family. This compound has been utilized in scientific research to explore the role of 5-HT1B receptors in various physiological and pathological processes.
Chemical Structure and Properties[edit]
SB-224289 is characterized by its specific binding affinity to the 5-HT1B receptor, which distinguishes it from other serotonin receptor subtypes. The molecular formula of SB-224289 is C19H20N4O, and it has a molecular weight of 320.39 g/mol. The compound is typically synthesized in laboratory settings for research purposes.
Mechanism of Action[edit]
As a selective antagonist, SB-224289 binds to the 5-HT1B receptor and inhibits its activity. The 5-HT1B receptor is a G protein-coupled receptor (GPCR) that is involved in the modulation of neurotransmitter release, particularly serotonin. By blocking this receptor, SB-224289 can alter serotonin signaling pathways, which has implications for understanding mood regulation, anxiety, and other neuropsychiatric conditions.
Research Applications[edit]
SB-224289 has been used extensively in preclinical studies to investigate the role of 5-HT1B receptors in the central nervous system. Some key areas of research include:
- Mood Disorders: Studies have explored how SB-224289 affects behaviors related to depression and anxiety, providing insights into potential therapeutic targets for these conditions.
- Migraine: The 5-HT1B receptor is implicated in the pathophysiology of migraines, and SB-224289 has been used to study its role in migraine models.
- Substance Use Disorders: Research has examined how SB-224289 influences the rewarding effects of drugs of abuse, contributing to the understanding of addiction mechanisms.
Pharmacokinetics[edit]
The pharmacokinetic profile of SB-224289 includes its absorption, distribution, metabolism, and excretion characteristics. These properties are crucial for determining the compound's efficacy and safety in experimental settings. However, detailed pharmacokinetic data specific to SB-224289 may vary depending on the study design and model organism used.
Safety and Toxicology[edit]
As with many research chemicals, the safety and toxicological profile of SB-224289 is primarily assessed in controlled laboratory environments. Researchers must adhere to safety guidelines and regulations when handling and administering this compound.
Also see[edit]
- 5-HT1B receptor
- Serotonin receptor
- Antagonist (pharmacology)
- Neurotransmitter
- G protein-coupled receptor
-
SB-224289

